Neil Singla, Chief Executive Officer of Lotus Clinical Research, Chaired the fourth annual American Pain Society Conference on Analgesic Trials (APS-CAT)

Kaufmann to provide company vision for the integration of the Skin Surveillance Program into dermatology and primary care practices

Asia Pacific biomedical refrigerators and freezers market is expected to register 5.4% CAGR over the forecast period.

Pediatric segment of multiparameter patient monitoring market will register 4%+ CAGR from 2019 to 2025

Study by Gladstone scientists finds blood protein destroys memory storage sites in the brain and may lead to new treatments

Robert Dworkin, Ph.D. Joins Lotus Clinical Research as Director, Chronic Pain Research to lead Lotus' chronic pain research programs

An unexpected brain region is important for Dravet Syndrome, finds study from the Gladstone Institutes

Focus will involve the use of cadavers for the purpose of presenting simulations of new techniques in Regenerative Medicine

Insight into how three of the world's most devastating viruses interact with human cells opens the door for much-needed treatments

Lotus Clinical Research LLC receives private equity backing; expands team with Jeffrey Kinell and Kurt Brykman joining board of directors

Lotus Clinical Research Presented at Pain Therapeutics in San Francisco on Development of Long-Acting Local Anesthetics

Parnell delivers 39% revenue growth and a $5.9 million year-to-date improvement in EBITDA as at the third quarter of 2018 compared to the same period in 2017, consolidates the return to profitability, and maintains full-year 2018 guidance at a 35 - 40% increase over 2017 revenue to $26 - $27 million and an EBITDA range of $5.5 - $6.5 million.

Researchers will use IASLC/LCFA funds to create new lung cancer treatments for never-smokers and patients whose cancer has spread

IDTechEx will be hosting a masterclass on Bioelectronics & Neuroprosthetics at the Santa Clara Convention Center, CA

The NIH funds an initiative at the Gladstone Institutes to assess the safety of CRISPR-like therapies in human tissues

OccuPro's FCE is used for assessing a client's readiness to return to work.

With generous support for research funding, The Ehlers-Danlos Society sponsors International Symposium in Ghent, Belgium, to accelerate collaborative global research into EDS, HSD, their related symptoms and associated conditions.